Download PDF
Rofo 2023; 195(05): 377-384
DOI: 10.1055/a-1999-7057
Review

Radiologic staging of peritoneal and retroperitoneal disease

Article in several languages: English | deutsch
Gabriel Glockzin
1   Department of Surgery, Munchen Klinik Bogenhausen, Munchen, Germany
,
Thomas Helmberger
2   Radiology, Neuroradiology and minimal-invasive Therapy, Munchen Klinik Bogenhausen, Munchen, Germany
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Peritoneal and retroperitoneal tumors consist of a heterogenous group of benign and malignant lesions of different origin. Due to often complex multidisciplinary treatment concepts in patients with peritoneal surface malignancies radiological imaging plays a pivotal role regarding the therapeutic options. Moreover, tumor entity, abdominal tumor distribution and common as well as rare differential diagnoses have to be taken into account. Using different radiological modalities non-invasive pretherapeutic diagnostics might be significantly improved.

Key Points: 

  • Diagnostic CT is a valuable part of the initial diagnostic approach to peritoneal surface malignancies.

  • Sensitivity might be increased by the additional use of dwMRI and PET/CT considering tumor entity and individual diagnostic issues.

  • The Peritoneal Cancer Index (PCI) should be determined independent of radiologic modality.

Citation Format

  • Glockzin G, Helmberger T. Radiologic staging of peritoneal and retroperitoneal disease. Fortschr Röntgenstr 2023; 195: 377 – 384

Key words

peritoneal surface malignancies - metastasis - radiological imaging - computed tomography - magnetic resonance imaging - positron emission tomography


Publication History

Received: 31 March 2022

Accepted: 08 December 2022

Article published online:
02 March 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 2009; 7: 5
    CrossrefPubMedSearch in Google Scholar
  • 2 Bushati M, Rovers KP, Sommariva A. et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol 2018; 44: 1942-1948
    CrossrefPubMedSearch in Google Scholar
  • 3 Govaerts K, Lurvink RJ, De Hingh I. et al. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 2021; 47: 11-35
    CrossrefPubMedSearch in Google Scholar
  • 4 Kusamura S, Kepenekian V, Villeneuve L. et al. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 2021; 47: 36-59
    CrossrefPubMedSearch in Google Scholar
  • 5 [Anonym]. WHO classification of tumours, Vol. 3: Soft tissue and bone tumours. 5. Aufl.. Lyon, France: IARC; 2020
    Search in Google Scholar
  • 6 Baheti AD, O'Malley RB, Kim S. et al. Soft-Tissue Sarcomas: An Update for Radiologists Based on the Revised 2013 World Health Organization Classification. Am J Roentgenol 2016; 206: 924-932
    CrossrefPubMedSearch in Google Scholar
  • 7 Diop AD, Fontarensky M, Montoriol PF. et al. CT imaging of peritoneal carcinomatosis and its mimics. Diagn Interv Imaging 2014; 95: 861-872
    CrossrefPubMedSearch in Google Scholar
  • 8 Piso P, Arnold D, Glockzin G. Challenges in the multidisciplinary management of stage IV colon and rectal cancer. Expert review of gastroenterology & hepatology 2015; 9: 317-326
    CrossrefPubMedSearch in Google Scholar
  • 9 Messiou C, Moskovic E, Vanel D. et al. Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm. Eur J Surg Oncol 2017; 43: 1191-1198
    CrossrefPubMedSearch in Google Scholar
  • 10 Mota M, Bezerra ROF, Garcia MRT. Practical approach to primary retroperitoneal masses in adults. Radiol Bras 2018; 51: 391-400
    CrossrefPubMedSearch in Google Scholar
  • 11 Wessling J, Ringe K, Juchems M. et al. Peritoneale und retroperitoneale Anatomie für Radiologen. Radiologie up2date 2020; 179-201
    Thieme ConnectPubMedSearch in Google Scholar
  • 12 Carr NJ, Cecil TD, Mohamed F. et al. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol 2016; 40: 14-26
    CrossrefPubMedSearch in Google Scholar
  • 13 Ceelen WP, Bracke ME. Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment. Lancet Oncol 2009; 10: 72-79
    CrossrefPubMedSearch in Google Scholar
  • 14 Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996; 82: 359-374
    CrossrefPubMedSearch in Google Scholar
  • 15 de Bree E, Koops W, Kroger R. et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 2004; 86: 64-73
    CrossrefPubMedSearch in Google Scholar
  • 16 Koh JL, Yan TD, Glenn D. et al. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 2009; 16: 327-333
    CrossrefPubMedSearch in Google Scholar
  • 17 Esquivel J, Chua TC, Stojadinovic A. et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 2010; 102: 565-570
    CrossrefPubMedSearch in Google Scholar
  • 18 Low RN, Barone RM. Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 2012; 19: 1394-1401
    CrossrefPubMedSearch in Google Scholar
  • 19 Low RN, Barone RM, Lucero J. Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 2015; 22: 1708-1715
    CrossrefPubMedSearch in Google Scholar
  • 20 Klumpp BD, Schwenzer N, Aschoff P. et al. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdom Imaging 2013; 38: 64-71
    CrossrefPubMedSearch in Google Scholar
  • 21 Goere D, Souadka A, Faron M. et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol 2015; 22: 2958-2964
    CrossrefPubMedSearch in Google Scholar
  • 22 Quenet F, Elias D, Roca L. et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2021; 22: 256-266
    CrossrefPubMedSearch in Google Scholar
  • 23 Elias D, Gilly F, Boutitie F. et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28: 63-68
    CrossrefPubMedSearch in Google Scholar
  • 24 Yan TD, Haveric N, Carmignani CP. et al. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 2005; 103: 839-849
    CrossrefPubMedSearch in Google Scholar
  • 25 Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-132
    CrossrefPubMedSearch in Google Scholar
  • 26 Sugarbaker PH, Sardi A, Brown G. et al. Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay. Int J Hyperthermia 2017; 33: 497-504
    CrossrefPubMedSearch in Google Scholar
  • 27 Laghi A, Bellini D, Rengo M. et al. Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. Radiol Med 2017; 122: 1-15
    CrossrefPubMedSearch in Google Scholar
  • 28 van 't Sant I, Engbersen MP, Bhairosing PA. et al. Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radiol 2020; 30: 3101-3112
    CrossrefPubMedSearch in Google Scholar
  • 29 Michielsen K, Vergote I, Op de Beeck K. et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 2014; 24: 889-901
    CrossrefPubMedSearch in Google Scholar
  • 30 van 't Sant I, Nerad E, Rijsemus CJV. et al. Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates. Eur J Surg Oncol 2022; 48: 462-469
    CrossrefPubMedSearch in Google Scholar
  • 31 Engbersen MP, Rijsemus CJV, Nederend J. et al. Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial. BMC Cancer 2021; 21: 464
    CrossrefPubMedSearch in Google Scholar
  • 32 Kim SJ, Lee SW. Diagnostic accuracy of (18)F-FDG PET/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis. Br J Radiol 2018; 91: 20170519
    CrossrefPubMedSearch in Google Scholar
  • 33 Gonzalez-Moreno S, Gonzalez-Bayon L, Ortega-Perez G. et al. Imaging of peritoneal carcinomatosis. Cancer J 2009; 15: 184-189
    CrossrefPubMedSearch in Google Scholar
  • 34 Satoh Y, Ichikawa T, Motosugi U. et al. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. Am J Roentgenol 2011; 196: 447-453
    CrossrefPubMedSearch in Google Scholar
  • 35 Klumpp B, Schwenzer NF, Gatidis S. et al. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT. Fortschr Röntgenstr 2014; 186: 359-366
    Thieme ConnectPubMedSearch in Google Scholar
  • 36 Dirisamer A, Schima W, Heinisch M. et al. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Eur J Radiol 2009; 69: 536-541
    CrossrefPubMedSearch in Google Scholar
  • 37 Jonsdottir B, Ripoll MA, Bergman A. et al. Validation of (18)F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study. Cancer Imaging 2021; 21: 34
    CrossrefPubMedSearch in Google Scholar